financetom
Business
financetom
/
Business
/
US FDA approves Guardant Health's blood-based cancer test
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Guardant Health's blood-based cancer test
Jul 29, 2024 3:49 AM

July 29 (Reuters) - The U.S. Food and Drug

Administration on Monday approved Guardant Health's ( GH ) blood

test to detect a cancer that starts in the colon or rectum.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved